Bei einigen der großen internationalen Konzerne der Prozessindustrie gibt es bald neue Führungsköpfe. Neben Dupont, Lyondell Basell und Lonza haben auch Johnson & Johnson, Pfizer und Jubilant Therapeutics Veränderungen in den Chefetagen angekündigt. PROCESS fasst die aktuellen Personalmeldungen für Sie zusammen.
Edward D. Breen who is currently the Executive Chairman at Dupont has also been handed over the Chief Executive Officer position by the Board of Directors at Dupont. In addition to this, Lori Koch has also been elected as the company’s Chief Financial Officer.
Dupont has appointed Amy G. Brady to its Board of Directors with effect from October 9, 2019. She is currently the Chief Information Officer (CIO), Executive Vice President at Keycorp which is a bank-based financial services company.
Dupont Electronics & Imaging has entered into an agreement with South Korean firm SK Siltron to sell its Compound Semiconductor Solutions business. The transaction is expected to close towards the end of this year.
Dow Dupont's board of directors has approved the previously announced separation of their Materials Science Division. As of April 1, the division is to become new Dow and an independent, publicly traded company.
Dow Dupont announced the members of the future boards of directors of Dow, Dupont, and Corteva Agriscience. Amongst others, Ed Breen will serve as executive chairman of the board of Dupont and Jeff M. Fettig will become non-executive chairman of Dow. Greg Page, retired chairman and chief executive officer of Cargill will serve as non-executive chairman of the board of Corteva Agriscience.
2015 war das Jahr der Mergers und Acquisitions (M&A). Um insgesamt 43 % auf einen Rekordwert von 4,5 Billionen Dollar stiegen die Übernahmen und Fusionen gegenüber dem Vorjahr weltweit. PROCESS stellt Ihnen die größten Deals der vergangenen 18 Monate ausführlich vor.